| 000 | 01661 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517115858.0 | ||
| 264 | 0 | _c20171030 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1933-2874 | ||
| 024 | 7 |
_a10.1016/j.jacl.2016.08.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStein, Evan | |
| 245 | 0 | 0 |
_aEfficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients. _h[electronic resource] |
| 260 |
_bJournal of clinical lipidology _c |
||
| 300 |
_a1212-22 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 |
_aAbdominal Pain _xetiology |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aApolipoproteins B _xblood |
| 650 | 0 | 4 |
_aAsthenia _xetiology |
| 650 | 0 | 4 | _aBlood Urea Nitrogen |
| 650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
| 650 | 0 | 4 |
_aCaproates _xadverse effects |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aHypercholesterolemia _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPlacebo Effect |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBays, Harold | |
| 700 | 1 | _aKoren, Michael | |
| 700 | 1 | _aBakker-Arkema, Rebecca | |
| 700 | 1 | _aBisgaier, Charles | |
| 773 | 0 |
_tJournal of clinical lipidology _gvol. 10 _gno. 5 _gp. 1212-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jacl.2016.08.002 _zAvailable from publisher's website |
| 999 |
_c26461617 _d26461617 |
||